Investigator
Martin P. Paulus
LAUREATE INSTITUTE FOR BRAIN RESEARCH · funded by NIDA, NIGMS
- Companies
- 4
- Grants
- 4
- Non-dilutive funding
- $6.6M
- First award
- Sep 15, 2017
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Apr 15, 2020.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- LAUREATE INSTITUTE FOR BRAIN RESEARCHMomentum in another area
NeuroGrant-only
- LAUREATE INSTITUTE FOR BRAIN RESEARCHMomentum in another area
Grant-only
- LAUREATE INSTITUTE FOR BRAIN RESEARCHMomentum in another area
NeuroGrant-only
- LAUREATE INSTITUTE FOR BRAIN RESEARCHMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U01
15/21 ABCD-USA Consortium: Research Project Site at LIBR
$2.0MApr 15, 2020NIDALAUREATE INSTITUTE FOR BRAIN RESEARCHNIH RePORTER · 11078203 (opens the source filing in a new tab)
- U01
15/21 ABCD-USA Consortium: Research Project Site at LIBR
$2.0MApr 15, 2020NIDALAUREATE INSTITUTE FOR BRAIN RESEARCHNIH RePORTER · 11301908 (opens the source filing in a new tab)
- P20
NeuroMAP Phase II - Administrative Core
$214kSep 15, 2017NIGMSLAUREATE INSTITUTE FOR BRAIN RESEARCHNIH RePORTER · 11145201 (opens the source filing in a new tab)
- P20
The Center for Neuroscience-based Mental Health Assessment and Prediction (NeuroMAP)
$2.4MSep 15, 2017NIGMSLAUREATE INSTITUTE FOR BRAIN RESEARCHNIH RePORTER · 11145200 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources